- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 6, 2025 | 39.04M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $10.25M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $2.84M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $26.42M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $48.44M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $77.82M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $5.49M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $13.14M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $6.18M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $13.94M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $39.85M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $54.84M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $43.51M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $58.78M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 38.32M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $5K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$25.8M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $106.74M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $130.19M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.69 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.69 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $6.45M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $21.24M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$26.34M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$27.69M |